Citations 1-10 of 13 total displayed.

News

News feature: Costly US anticancer drugs pose problems for doctors and patients

Fred Charatan

BMJ 2008;337:a778, doi: 10.1136/bmj.a778, (Published 14 July 2008)

[Extract] [Full text]  

Letters

Critical issue is rapidity of review of new drugs

Alan Rodger

BMJ 2008;337:a779, doi: 10.1136/bmj.a779, (Published 14 July 2008)

[Extract] [Full text]  

Minerva

Victoria H Smith and Stephen K Jones

BMJ 2008;337:a793, doi: 10.1136/bmj.a793, (Published 14 July 2008)

[Full text]  

Letters

Why not adopt the blacklist of yore?

L Sam Lewis

BMJ 2008;337:a807, doi: 10.1136/bmj.a807, (Published 14 July 2008)

[Extract] [Full text]  

Minerva

Susannah Hoey, Sai Yee Chuah, Helen Poole, and Sam Allen

BMJ 2008;337:a587, doi: 10.1136/bmj.a587, (Published 3 July 2008)

[Full text]  

Editor's choice

The NHS in our hands

Fiona Godlee

BMJ 2008;337:a663, doi: 10.1136/bmj.a663, (Published 2 July 2008)

[Extract] [Full text]  

Practice

Fatal reactivation of hepatitis B after chemotherapy for lymphoma

Richard Dillon, Gideon M Hirschfield, Michael E D Allison, and Kanchan P Rege

BMJ 2008;337:a423, doi: 10.1136/bmj.39490.680498.BE, (Published 1 July 2008)

[Extract] [Full text]  

Editorials

Drugs for cancer and copayments

Ilora Finlay and Nigel Crisp

BMJ 2008;337:a527, doi: 10.1136/bmj.a527, (Published 30 June 2008)

[Extract] [Full text]  

Views & reviews

Top-ups for cancer drugs: can we kill the zombie for good?

Cam Donaldson

BMJ 2008;337:a578, doi: 10.1136/bmj.a578, (Published 30 June 2008)

[Extract] [Full text]  

News

NHS might have to attract more private money if it is to improve standards

Rebecca Coombes

BMJ 2008;336:1457, doi: 10.1136/bmj.a440,

[Extract] [Full text] [PDF]